Triple-negative breast cancers (TNBC), a subtype of breast cancer that is characterized by absence of estrogen receptors (ER), progesterone receptors (PR), and a lack of overexpression of human epidermal growth factor receptor 2 (HER2), account for about 15% of all breast cancer cases [2]. This evidence concerns the gene PGR and triple-negative breast carcinoma.